Ex-FDA com­mish Scott Got­tlieb makes a quick jump back on­to the mon­ey side of biotech

Well, that didn’t take long.

Just a lit­tle more than a month af­ter Scott Got­tlieb’s sur­prise ex­it at the FDA, the for­mer com­mish is back on the mon­ey side of the in­dus­try he had been in charge of reg­u­lat­ing for 2 years. He’s re­join­ing New En­ter­prise As­so­ciates as a full-time in­vest­ing part­ner, where he ex­pects to start back­ing biotech star­tups and sit­ting on boards again.

Ax­ios got the scoop on Wednes­day, which Got­tlieb — who’s been well known for keep­ing his ed­i­to­r­i­al con­tacts close — quick­ly con­firmed in a Tweet.

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER